# March Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/march-biosciences

- Industry: Biotechnology
- Headquarters: Houston, US
- Website: www.march.bio
- Total disclosed funding: $22M
- Latest round: Series A (Oct 7, 2024)
- Investors on record: 11

## About

Based in Texas, US, and founded in 2021 by Sarah Hein (CEO), Max Mamonkin, and Malcolm Brenner, March Biosciences, Inc. operates as a biotechnology company that develops drugs for patients suffering from hematological cancers and offers treatment to patients with leukemias and lymphomas. In October 2024, March Biosciences, Inc. raised GBP 22 million in series A funding led by new investor 4BIO Capital Partners, with participation from returning investors Texas Medical Center Ventures, Cancer Focus Fund, and Small Ventures. Other new investors Mission BioCapital, KdT Ventures, Alexandria Venture Investments, Volnay, Modi Ventures, and Portal Innovations also participated in the round.

March Biosciences is a clinical-stage cell therapy firm comprised of cell therapy experts and medication developers. The company is working on a pipeline of new cell treatments for cancer treatment, with an emphasis on T-cell cancers. In addition, the comapny leads the development and commercialization of cell treatments that aim to alter the lives of cancer patients, driven by a vision to reinvent cancer therapy.

The company plans to use the October 2024 funding to support March Biosciences, Inc.'s Phase 2 clinical development CAR-T therapy, MB-105, optimize manufacturing processes, and advance additional pipeline products.

## Funding rounds

- Series A, Oct 7, 2024, $22M — Alexandria Venture Investments, Small Ventures, Texas Medical Center Ventures, Mission Biocapital, 4BIO Capital Partners, KdT Ventures, Cancer Focus Fund, Portal Innovations, Volnay, Modi Ventures, Mansueto Office

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Small Ventures (https://capitalatlas.ai/funds/small-ventures) — Series A
- Texas Medical Center Ventures (https://capitalatlas.ai/funds/texas-medical-center-ventures) — Series A
- Mission Biocapital (https://capitalatlas.ai/funds/mission-biocapital) — Series A
- 4BIO Capital Partners (https://capitalatlas.ai/funds/4bio-capital-partners) — Series A
- KdT Ventures (https://capitalatlas.ai/funds/kdt-ventures) — Series A
- Cancer Focus Fund (https://capitalatlas.ai/funds/cancer-focus-fund) — Series A
- Portal Innovations (https://capitalatlas.ai/funds/portal-innovations) — Series A
- Volnay — Series A
- Modi Ventures (https://capitalatlas.ai/funds/modi-ventures) — Series A
- Mansueto Office — Series A